Prostate Cancer Studies

Extreme hypofractionated proton radiotherapy for prostate cancer using pencil beam scanning: Dosimetry, acute toxicity and preliminary results

Quality of life and toxicity from passively scattered and spot-scanning proton beam therapy for localized prostate cancer

Comparison of conventional-dose vs high-dose conformal radiation therapy in clinically localized adenocarcinoma of the prostate

Comparison of high-dose proton radiotherapy and brachytherapy in localized prostate cancer: a case-matched analysis

Dose-volume comparison of proton therapy and intensity-modulated radiotherapy for prostate cancer

Early outcomes from three prospective trials of image-guided proton therapy for prostate cancer

Erectile function, incontinence, and other quality of life outcomes following proton therapy for prostate cancer in men 60 years old and younger

Five-Year Outcomes from 3 Prospective Trials of Image-Guided Proton Therapy for Prostate Cancer

Hypo-fractionated passively scattered proton radiotherapy for low-and intermediate-risk prostate cancer is not associated with post-treatment testosterone suppression

Long-term quality of life outcome after proton beam monotherapy for localized prostate cancer

Management of complications of prostate cancer treatment

Patient-reported long-term outcomes after conventional and high-dose combined proton and photon radiation for early prostate cancer

Urinary functional outcomes and toxicity five years after proton therapy for low-and intermediate-risk prostate cancer: results of two prospective trials

Long-term Efficacy and Toxicity of Hypofractionated Salvage Radiation Therapy for Biochemically Recurrent Prostate Cancer